Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)

14.60
Delayed Data
As of Jan 20
 +0.97 / +7.12%
Today’s Change
9.83
Today|||52-Week Range
20.48
+5.57%
Year-to-Date

Today’s Trading

Previous close13.63
Today’s open13.91
Day’s range13.82 - 14.91
Volume6,122,451
Average volume (3 months)1,723,747
Market cap$1.7B
Data as of 5:04pm ET, 01/20/2021

Growth & Valuation

Earnings growth (last year)-76.03%
Earnings growth (this year)+26.88%
Earnings growth (next 5 years)--
Revenue growth (last year)-31.32%
P/E ratioNM
Price/Sales5,930.65
Price/Book5.44

Competitors

 Today’s
change
Today’s
% change
TBIOTranslate Bio Inc-0.72-3.13%
QUREUniqure NV+0.78+2.05%
DRNADicerna Pharmaceutic...-0.27-1.15%
HRTXHeron Therapeutics I...-0.36-2.01%
Data as of 4:00pm ET, 01/20/2021

Financials

Next reporting dateMarch 12, 2021
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$318.0K
Annual profit (last year)-$123.8M
Net profit margin-38,945.28%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Victoria, British Columbia

Forecasts